Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Frontiers in Immunology|August 22, 2024
Traversing the bench to bedside journey for iNKT cell therapiesJulie O'Neal, Melissa Mavers, Reyka G Jayasinghe, et al.Frontiers in Molecular Biosciences|September 9, 2015
Current theoretical models fail to predict the topological complexity of the human genomeJavier Arsuaga, Reyka G Jayasinghe, Robert G Scharein, et al.Cell Reports|April 30, 2025
Single-cell transcriptomic profiling reveals diversity in human iNKT cells across hematologic tissuesReyka G Jayasinghe, Derek Hollingsworth, Nathan C Schedler, et al.Nature Communications|May 31, 2020
Evolution and structure of clinically relevant gene fusions in multiple myelomaSteven M Foltz, Qingsong Gao, Christopher J Yoon, et al.Frontiers in Immunology|September 25, 2023
Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant modelsRamzi Abboud, Sena Kim, Karl Staser, et al.Nature Communications|November 5, 2020
Discovery of driver non-coding splice-site-creating mutations in cancerSong Cao, Daniel Cui Zhou, Clara Oh, et al.Iscience|January 23, 2025
Germline predisposition in multiple myelomaFernanda Martins Rodrigues, Jagoda Jasielec, Melody Perpich, et al.Research Square|October 3, 2025
CD1d+ Goblet Cells Expand Colon-Resident Immature, Intermediate and Differentiated iNKT Cells to Limit ColitisVini John, Bibiana Barrios, Jacqueline D Wang, et al.Leukemia|April 15, 2022
CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cellsJulie O'Neal, Julie K Ritchey, Matthew L Cooper, et al.Blood|November 22, 2024
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantationRamzi Abboud, Mark A Schroeder, Michael P Rettig, et al.Pageof 4